Waters Corporation has entered a reseller agreement with TetraScience, a cloud technology innovator powering transf...
PerkinElmer, Inc, has launched the PerkinElmer® COVID-19 Antigen Test for the qualitative detect...
Gavi, the Vaccine Alliance announced today that it had signed a memorandum of understanding (MoU) with Novavax that, com...
Pelican BioThermal, the global name in temperature-controlled packaging, partners with industry experts to offer Innovat...
Agilent Technologies Inc. has announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent A...
Significant advances to the diagnosis of tuberculosis (TB) and drug resistance in adults, adolescents and children are...
The Vanquish Online 2D-LC system leverages the performance and ease of use of the innovative Vanquish technology, while ...
The World Federation of Neurology is pleased to announce its launch of the Brain Health Initiative, a global campaign to...
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products has announced that...
GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has r...
WHo at a media briefing on Feb 10, 2021, updated that globally around 128 million vaccine doses administered so far and ...
The US Food and Drug Administration has issued an emergency use authorisation (EUA) for bamlanivimab and etese...
This is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dos...
SmartBreast Corporation (SmartBreast™), a privately held company with headquarters near Pittsburgh, US&n...
While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...
In response to the alcohol-based hand sanitiser quality incidents reported across the globe, the US Pharmacopeia (USP) i...
A new World Health Organization (WHO) road map for neglected tropical diseases (NTDs) proposes ambitious targets and inn...
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced th...
